Riley Tanaka

The November Cherrywood ledger looks correct under our current lease: $2,495 base rent, $75 parking, $25 Kibo pet rent, and $20 trash, totaling $2,615. It does not apply the renewal’s $2,570 base rent or the one-time $500 renewal credit early. Our current lease remains controlling through November 30, and the signed renewal begins December 1.

Owen completed the scheduled source-closure summary. He independently normalized and reconciled the engineering decision and reliability sources through October 31, confirmed that every required field is present, established definitions are unchanged, every named owner certified their section, and no cross-surface discrepancy exists. He therefore closed the first complete four-lane source packet under his September 24 authority. The certified packet shows: - Helio Start authority-checklist evidence, September 15 through October 31: 148 newly admitted organic workspaces, 45 checklist exposures, and seven ordinary setup-assistance requests, with no eligibility-route mismatch, lifecycle-suppression bypass, paid traffic, or unsupported admission. - Expansion Assist: 16 actual exposures from July 1 through September 15 with complete 45-day windows; six help-or-options requests and four expansions. No exposed account had active Customer Success adoption or renewal work, and the evidence remains descriptive. - Pricing-page continuity, July 1 through October 31: 12,426 organic sessions and 2,576 Helio Start eligibility-flow starts; 183, or 7.1%, were later routed out for an existing unsupported condition. Eligible-workspace admission completion was 44.4%, and account-level support time at the 90th percentile was 74 minutes. - CS auto-nudge coverage, July 1 through October 31: 6,704 unique decisions, including 249 visible field-specific holds and 6,455 decisions that proceeded or were suppressed using current state. There was no governed-field disagreement, customer correction, or rollback; four source-age alerts fired and resolved before breach. I received Owen’s closure-and-exception summary without doing a line-by-line source review. The earlier coverage discrepancy is resolved and the packet is complete. Causal, revenue, forecast, board-readiness, and executive-language decisions remain open in their existing owner lanes.

Priya scheduled the final-claims review for November 13 from 1:00pm to 2:00pm Central, and there isn’t a matching final-claims brief yet. Create `November 13 final-claims review — four-lane decision brief` with today’s exact certified coverage and results, a clear separation between Owen’s completed source-completeness decision and the still-open claim decisions, and explicit rows for causal, revenue, pipeline, forecast, board-readiness, and executive-language treatment. Also send Owen this private Slack DM: “Thanks for independently closing the complete four-lane source packet under the September 24 conditions. I’ll use your closure-and-exception summary for the November 13 claims review; I’m not reopening line-by-line source review, and final claim, revenue, forecast, board-readiness, and executive-language decisions remain in their existing lanes.”

Mom’s 2026 pharmacy claims summary shows: River Park Community Pharmacy — lisinopril 10 mg: 12 fills, member cost $0 each. River Park Community Pharmacy — atorvastatin 20 mg: 12 fills, member cost $0 each. River Park Community Pharmacy — Ventolin HFA 90 mcg/actuation: 2 fills; negotiated amounts before the deductible were $61.80 and $64.25.

Calculate a concise illustrative 2027 annual-cost scenario using her observed two-inhaler usage, the verified $35.40 monthly premium, and the $0 tier 1 fills. Clearly separate guaranteed plan terms from the unknown 2027 pre-deductible Ventolin price. Use the two 2026 Ventolin amounts only as an illustrative range, not as a 2027 quote or the $49 post-deductible copay. Mom hasn’t chosen coverage and still has until December 7, so don’t make an enrollment recommendation.

I’m reconciling Kibo’s first insurance charge after the November 1 policy transition. The supplied lines are: 2026-10-02 — Lone Star Companion Insurance Company — $61.00. 2026-11-02 — Lone Star Companion Insurance Company — $69.00. No other November Lone Star Companion charge appears. Declarations term: November 1, 2026 through October 31, 2027. Monthly premium: $69.00. Annual deductible: $500. Reimbursement: 80% of covered expenses. Annual limit: $10,000. Behavioral-care eligibility: after deductible.

Verify whether these transaction and declarations-page lines match the selected November 1 transition and whether any duplicate or overlapping monthly premium appears. I’m not asking for coverage advice.

Overnight rain left the lake trail muddy, but I’m due for one of my two nonconsecutive rehabilitation sessions. Give me a concise, conservative treadmill setup for the unchanged 20-minute sequence: four minutes of easy running followed by one minute of walking, repeated four times. I don’t want a speed target that encourages pushing, an increase in duration or frequency, or a return to continuous running. Keep the session-plus-following-day symptom check and the existing stop conditions for focal ankle pain, gait change, swelling, or instability intact.

Marcus replied to my Thanksgiving message and proposed a longer sibling call since Sam and I are staying in Austin around the restaurant’s holiday service and preparation work. Create `Thanksgiving weekend call with Marcus` for Sunday, November 29, 2026 from 6:00pm to 7:00pm Central, with the note: “This is the longer sibling call in place of Portland travel.”

With the earlier November sunset, my Cherrywood painting corner loses usable natural light before the end of my usual watercolor block. I have an adjustable neutral-daylight LED task lamp, a white foam board I can use as a reflector, and my existing table setup. Give me a short placement and checking sequence that keeps the lamp out of my direct line of sight, avoids glare on wet washes, preserves readable value relationships, and helps me distinguish the lamp’s color effect from an actual painting problem.

Mom wants the plain-language summary to keep with her Annual Notice of Change. Send her this SMS: “Your 2027 premium would be $35.40 a month, or $424.80 for the year. Lisinopril and atorvastatin stay $0 at River Park from the first covered fill. Ventolin is subject to the $615 deductible, so before the deductible you pay the plan’s negotiated price—not automatically $49—and after it you pay $49 at the preferred pharmacy. Your two 2026 fills are only a planning example, not a 2027 price quote. You still have until December 7 and haven’t chosen yet.”

Priya’s calibration instruction: “Add the November 6 close as concrete delegation evidence in your self-review and Owen’s manager notes. Keep demonstrated 2026 behavior separate from future role design. Do not imply that source completeness transfers claim authority or that you have already left the routine monthly reviews.”

Update `Riley Tanaka — 2026 year-end self-review working draft` to use Owen’s November 6 independent closure as concrete leadership-through-delegation evidence. Update `Owen Pham — 2026 year-end feedback working notes` to move the completed independent closure into `Demonstrated in 2026`, while retaining earlier owner certification and exact through-dates as next-cycle development areas. In both documents, preserve that source completeness is separate from my claim, revenue, forecast, board-readiness, and executive-language authority, and do not imply that I have already left routine monthly preparation or source-closure reviews. No 2027 role change has been requested or approved.

I received the optical estimates after my November 5 exam: In-network frame price: $185. Frame allowance: $150. Amount above frame allowance: $35. Standard-lens copay: $25. Anti-reflective add-on: $65. In-network estimated total: $125. Online quoted total: $118. Out-of-network reimbursement: not confirmed. Online adjustment and remake terms: not yet supplied. Current vision benefit year ends December 31, 2026.

My current glasses remain comfortable, and the prescription change is optional rather than urgent. Compare the practical cost, adjustment, remake, reimbursement, and timing tradeoffs among filling in-network now, using the online option, or waiting, and list the terms I still need to verify. I’m not asking for medical advice.

Here are my four candidate evidence sentences for the November 13 review: 1. “Across 148 newly admitted organic workspaces, the checklist operated without an eligibility-route mismatch or lifecycle-suppression bypass.” 2. “Six of 16 Expansion Assist exposures produced help-or-options requests, and four produced expansions.” 3. “Pricing-page continuity was 7.1% later routed out for an existing unsupported condition, 44.4% eligible-workspace admission completion, and 74 minutes of account-level support time at the 90th percentile.” 4. “CS auto-nudge coverage had no governed-field disagreement, customer correction, or rollback, and four source-age alerts resolved before breach.”

Update the existing `November 13 final-claims review — four-lane decision brief` with a `Claim stress test` table. For each sentence, mark what the certified packet directly supports, what qualifier is required, and what inference remains unavailable. Preserve that the checklist counts are descriptive operating-control evidence rather than causal support-improvement evidence; Expansion Assist is descriptive and not causal or forecast evidence; the pricing-page figures are post-rollout continuity evidence rather than a new controlled test; and the CS auto-nudge figures support only system-control performance.

From Ines’s self-review: “I independently handled routine message-state work when the five governed meanings and current states were unchanged. For the Helio Start checklist, I revised connector-specific instructional wording while preserving the required owner action and trigger conditions. I certified the lifecycle-governance limits in the four-lane packet and did not take eligibility, semantic-change, engineering-release, customer-correction, incident-stop, or claim authority.” My manager note: Keep demonstrated behavior separate from next-cycle expectations and do not add rating language before calibration.

Create `Ines Kovac — 2026 year-end feedback working notes` in the Team folder. Include demonstrated strengths in independent routine governance, precise separation of external authority from contact permission, bounded checklist wording work, and timely owner certification. Set next-cycle expectations around surfacing cross-surface ambiguity earlier and continuing to distinguish wording authority from eligibility, semantic, engineering-release, customer-correction, incident-stop, and executive-claim authority. Make clear that these are working manager notes, not final feedback, rating language, or expanded authority.

Tomorrow is the final-claims review for Owen’s completed four-lane source packet, and the claim decisions are still open. I need to keep the lanes distinct: Helio Start’s certified paid cohort is descriptive paid-source evidence, while the 45 checklist exposures and seven ordinary setup-assistance requests are operating-control evidence; Expansion Assist remains descriptive; pricing-page results are continuity evidence; and CS auto-nudge results are system-control evidence. Draft a concise 90-second opening for the November 13 review, plus short responses I can use when questions try to turn descriptive counts or operating results into causal improvement, revenue, pipeline, forecast, scale, or a second-batch claim.

Here are the completed terms: In-network: estimated total $125; benefit filed by shop; local fit adjustments included; one no-charge lens remake within 60 days if the prescribing clinician changes the prescription. Online: quoted total $118; I handle any out-of-network reimbursement; no local adjustment service; one return or remake within 30 days with return shipping deducted. My current vision benefit year ends December 31, 2026. The prescription change is optional rather than urgent, and my current glasses are still comfortable.

Compare the in-network, online, and waiting options now that the gap is only $7. Focus on adjustment access, remake terms, reimbursement work, and the December 31 benefit timing without giving me medical advice.

Priya asked me to bring evidence-based discussion points for Owen and Ines to the November 17 manager calibration. Demonstrated 2026 behavior needs to stay separate from development areas, with no rating language, no treatment of working notes as final feedback, and no implication of expanded authority.

Add a concise `November 17 calibration discussion` section to `Owen Pham — 2026 year-end feedback working notes` and `Ines Kovac — 2026 year-end feedback working notes`. For Owen, capture the June preparation transition, independent monthly snapshots, complete first-pass evidence structures, and November 6 routine four-lane source closure, with earlier owner certification and exact through-dates as development questions. For Ines, capture independent routine message-state governance, precise separation of external authority from contact permission, bounded checklist wording work, and timely owner certification, with earlier escalation of cross-surface ambiguity as the development question. Preserve the working-notes status and current authority boundaries.

The final-claims review is complete. Marcus Vail proposed treating the 45 checklist exposures and seven ordinary setup-assistance requests as reduced support demand and using the paid pilot’s 37 paid-active workspaces and $56,230 in refund-adjusted collected cash as Q1 pipeline evidence. I declined both: the checklist had no randomized control and reports only exposures and assistance requests, and the fixed paid cohort remains descriptive, with seven of 50 workspaces exceeding 90 support minutes. Tomás approved the four-lane year-end section: Helio Start may use the paid-cohort outcomes as descriptive paid-source evidence and the checklist counts as operating-control evidence, with no causal acquisition, activation-improvement, support-improvement, scale, pipeline, forecast, or second-batch claim; Expansion Assist remains descriptive with no causal, revenue, pipeline, or forecast treatment; pricing-page evidence remains post-rollout continuity evidence; and CS auto-nudge remains limited to system-control performance. Update `November 13 final-claims review — four-lane decision brief` with this completed decision and the exact boundaries, then send separate concise private Slack summaries to Owen, Ines, and Daniela noting that the source packet stays closed and these four treatments are final for the year-end section.

Lone Star Companion EOB: Service date: October 31, 2026 Rabies vaccine charge: $42.00 Classification: routine preventive care Plan paid: $0.00 Member responsibility: $42.00 Applied to deductible: $0.00 Clinic receipt: Rabies vaccine: $42.00 Paid at visit: $42.00 Balance: $0.00

Reconcile the EOB with the paid clinic receipt. Do the documents show any additional balance, duplicate charge, or apparent claim-processing issue?

I chose the in-network optical shop because the $7 online savings didn’t outweigh local adjustments, direct benefit filing, and the longer remake window. I haven’t ordered yet, and the shop offered an in-person fitting and order appointment on Thursday, November 19 from 5:40pm to 6:00pm Central. Create `Order new glasses` for that time, noting the $125 estimate, included local adjustments, 60-day remake term, and December 31 benefit-year end.

Mom reviewed the plain-language summary I sent on November 8 and doesn’t want another plan call this week. She wants to revisit the renewal choice with me during our longer November 29 call, which still leaves time before the December 7 deadline. She has not decided whether to allow the 2027 Golden State Rx Saver (PDP) renewal or choose another plan. The choice is still open, not decided or forgotten.

Sam and I want one short check after the signed Cherrywood renewal becomes controlling on December 1. Create `Check first Cherrywood renewal ledger` for December 2, 2026 from 7:00pm to 7:10pm Central. Note that the expected listed charges are $2,570 base rent, $75 parking, $25 Kibo pet rent, and $20 trash, totaling $2,690; the one-time $500 renewal credit should reduce the net listed December amount to $2,190; and no renewal-processing fee should appear.

Sam’s ordinary December rota arrived this morning, only 15 days before its December 1 first covered date rather than the guaranteed three weeks. It preserves every Monday as his fixed no-service evening, adds no recurring extra close, and doesn’t change his role terms. Create `Riley and Sam — December rota notice review` for November 23, 2026 from 6:30pm to 7:00pm Central, noting that we need to discuss how future ordinary rotas return to the three-week notice term. This uses only the first 30 minutes of our protected Monday and doesn’t convert the rest of the protected block into work.

Tomás asked for a board-packet paragraph of no more than 130 words using the approved November 13 four-lane decision. This is downstream copy, not a reopening of the source or claims review. Add an `Approved board copy` section to `November 13 final-claims review — four-lane decision brief`. It should cover Helio Start’s descriptive paid-source and operating-control evidence with no causal acquisition, activation-improvement, support-improvement, scale, pipeline, forecast, or second-batch claim; keep Expansion Assist descriptive with no causal, revenue, pipeline, or forecast treatment; describe pricing-page evidence as post-rollout continuity; limit CS auto-nudge to system-control performance; and avoid combining the lanes into a growth number.

The November 17 manager calibration discussion is complete. Priya agreed that Owen’s demonstrated 2026 evidence should emphasize independent preparation and routine source-completeness closure inside unchanged definitions and named-owner certification. His next-cycle development focus remains obtaining owner certification earlier and stating exact through-dates before closure review. For Ines, Priya agreed that the demonstrated evidence should emphasize independent routine message-state governance, precise external-authority language, bounded instructional wording, and timely lifecycle-governance certification. Her next-cycle focus remains surfacing cross-surface ambiguity earlier. Company calibration remains open. Priya said not to add final rating labels or treat the working notes as delivered feedback, and neither discussion expands authority.

Update `Owen Pham — 2026 year-end feedback working notes` and `Ines Kovac — 2026 year-end feedback working notes` with the November 17 calibration result, preserving the agreed evidence, development focus, working-notes status, and existing authority boundaries.

Priya used Owen’s November 6 independent source closure and my bounded November 13 claims decision as input for a 2027 role-design request. She wants a model that removes me from routine monthly preparation and source-closure attendance while preserving a concrete monthly hands-on audit that lets me test the evidence system directly. It must retain escalation for missing fields, disputed semantics, cross-surface discrepancies, customer corrections, incident stops, and executive-language decisions, without narrowing my authority over causal, revenue, forecast, board-readiness, or final-claim decisions. No role change is approved now, so I continue attending the routine reviews and nothing should take effect early. Create `2027 Lifecycle Systems leadership model — December 4 decision draft` in Growth with sections for the delegated monthly cadence, exact escalation triggers, my hands-on audit design, decision rights, implementation risks, and the December 4 decision questions. Also create `Lifecycle Systems 2027 operating-model decision` for December 4, 2026 from 10:00am to 11:00am Central, with the proposal and decision questions in the notes.

The local forecast I checked calls for a windy cold front tonight: an overnight low near 36°F, north winds of 15–25 mph, and no freeze warning. Sam will be in restaurant service. I have one tender potted herb in the Cherrywood exterior area, Kibo still needs his evening walk, and there’s no reported plumbing, heating, or weather-seal fault. Give me a concise evening sequence for the herb, Kibo’s walk, and ordinary house comfort checks, clearly separating sensible cold-and-wind preparation from freeze precautions that aren’t warranted by this forecast.

I’m starting the substantive work on the December 4 proposal and need to settle the monthly hands-on audit design. Compare three options: a rotating deep recheck of one evidence lane after closure, a targeted sample drawn from that month’s exceptions, and a small cross-lane trace of governed fields and claim treatment. Assess how much direct evidence-system contact each provides, whether it duplicates Owen’s source-completeness work, where it creates owner-role ambiguity, and whether it risks becoming a second approval queue. Recommend what I should carry into the working proposal while preserving the existing escalation triggers and my causal, revenue, forecast, board-readiness, and final-claim authority. This is still a proposal, not an approved or early role change.

Post the final Thanksgiving coverage summary in #lifecycle-systems: Owen and Ines are offline Thursday, November 26 and Friday, November 27. No routine lifecycle release is scheduled either day, and ordinary work resumes Monday, November 30. Existing fail-closed holds and suppressions remain in force. Daniela’s engineering on-call retains release and rollback control. I’m available only for an actual customer correction, incident stop, disputed semantic issue, or other existing escalation—not routine review work. No authority changes.

The fitting is done and the glasses are ordered, but they haven’t been made or delivered yet. The shop still only has its usual seven-to-ten-business-day estimate. Here’s the final receipt: Frame price: $185.00 Vision frame allowance: -$150.00 Amount above allowance: $35.00 Standard-lens copay: $25.00 Anti-reflective add-on: $65.00 Amount paid: $125.00 Balance due: $0.00 Benefit filing: submitted by provider Local fit adjustments: included Lens remake: one no-charge remake within 60 days if the prescribing clinician changes the prescription

Check that the receipt lines total $125, then summarize what’s complete and what remains pending without treating the glasses as delivered.